Advanced search
Publication Cover
Cancer Biology & Therapy Volume 15, 2014 - Issue 4
Submit an article Journal homepage
1,496
Views
38
CrossRef citations to date
0
Altmetric
Research Paper

Loss of GATA3 in bladder cancer promotes cell migration and invasion

Yi Li Department of Pathology and Laboratory Medicine; University of Rochester Medical Center; Rochester, NY USA; Department of Urology; 2nd Affiliated Hospital; Zhejiang University School of Medicine; Hangzhou, PR China
,
Hitoshi Ishiguro Department of Pathology and Laboratory Medicine; University of Rochester Medical Center; Rochester, NY USA; Departments of Pathology and Urology; Johns hopkins University school of Medicine; Baltimore, MD UsA
,
Takashi Kawahara Department of Pathology and Laboratory Medicine; University of Rochester Medical Center; Rochester, NY USA; Departments of Pathology and Urology; Johns hopkins University school of Medicine; Baltimore, MD UsA
,
Eiji Kashiwagi Departments of Pathology and Urology; Johns hopkins University school of Medicine; Baltimore, MD UsA
,
Koji Izumi Department of Pathology and Laboratory Medicine; University of Rochester Medical Center; Rochester, NY USA
&
Hiroshi Miyamoto Department of Pathology and Laboratory Medicine; University of Rochester Medical Center; Rochester, NY USA; Departments of Pathology and Urology; Johns hopkins University school of Medicine; Baltimore, MD UsACorrespondence[email protected]
Pages 428-435 | Received 16 Oct 2013, Accepted 22 Dec 2013, Published online: 21 Jan 2014

Citations (38)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Marwa Mohammed Serag Eldien, Asmaa Gaber Abdou, Gehad Raafat Amein Elghrabawy, Alshimaa Mahmoud Alhanafy & Shereen Fathy Mahmoud. (2021) Stratification of urothelial bladder carcinoma depending on immunohistochemical expression of GATA3 and CK5/6. Journal of Immunoassay and Immunochemistry 42:6, pages 662-678.
Read now
Chenglu Wang, Shuang Yang, Lu Jin, Guangcheng Dai, Qiu Yao, Han Xiang, Yongsheng Zhang, Xiaolong Liu & Boxin Xue. (2020) Biological and Clinical Significance of GATA3 Detected from TCGA Database and FFPE Sample in Bladder Cancer Patients. OncoTargets and Therapy 13, pages 945-958.
Read now

Articles from other publishers (36)

Z VARCHULOVÁ NOVÁKOVÁ, M KUNIAKOVÁ, S ŽIARAN & Š HARSÁNYI. (2023) Molecular Biomarkers of Bladder Cancer: A Mini-Review. Physiological Research 72:S3, pages S247-S256.
Crossref
Athanasios Angelakis, Ioanna Soulioti & Michael Filippakis. (2023) Diagnosis of acute myeloid leukaemia on microarray gene expression data using categorical gradient boosted trees. Heliyon 9:10, pages e20530.
Crossref
Hristo Popov, Peter Ghenev & George S Stoyanov. (2023) Role of GATA3 in Early-Stage Urothelial Bladder Carcinoma Local Recurrence. Cureus.
Crossref
Jef Haerinck, Steven Goossens & Geert Berx. (2023) The epithelial–mesenchymal plasticity landscape: principles of design and mechanisms of regulation. Nature Reviews Genetics 24:9, pages 590-609.
Crossref
Eirini-Chrisovalanto Bota, Dimitra Koumoundourou, Panagiota Ravazoula, Vasiliki Zolota, Charalampia Psachoulia, Maria Kardari, Theodoros Karampitsakos, Argyrios Tzouvelekis, Vasiliki Tzelepi & Fotios Sampsonas. (2023) A comprehensive analysis of GATA3 expression in carcinomas of various origins with emphasis on lung carcinomas. Monaldi Archives for Chest Disease.
Crossref
Daeseon Yoo, Kyueng-Whan Min, Jung-Soo Pyo & Nae Yu Kim. (2023) Diagnostic and Prognostic Roles of GATA3 Immunohistochemistry in Urothelial Carcinoma. Medicina 59:8, pages 1452.
Crossref
Meenatai Naik, BVishal Rao, Sundaram Challa, Daphne Fonseca, SMurthy Sudha, Ashwin Giridhar, Rakesh Sharma, KV. V. N. Raju & TSubramanyeshwar Rao. (2023) Utility of GATA-3 and associated immunohistochemical markers in the differential diagnosis of poorly differentiated urothelial carcinoma. Journal of Cancer Research and Therapeutics 19:8, pages 0.
Crossref
Ting Luo, Yangyang Pan, Yuhao Liu, Jun Zheng, Zhaowei Zhuang, Zuodong Ren, Jiaojiao Zhu, Yongqing Gu & Yan Zeng. (2022) LANA regulates miR‐155/GATA3 signaling axis by enhancing c‐Jun/c‐Fos interaction to promote the proliferation and migration of KSHV‐infected cells. Journal of Medical Virology 95:1.
Crossref
Henning Plage, Henrik Samtleben, Sebastian Hofbauer, Kira Kornienko, Sarah Weinberger, Paul Giacomo Bruch, Sefer Elezkurtaj, Florian Roßner, Simon Schallenberg, Martina Kluth, Maximilian Lennartz, Niclas C. Blessin, Andreas H. Marx, Margit Fisch, Michael Rink, Marcin Slojewski, Krystian Kaczmarek, Thorsten Ecke, Steffen Hallmann, Stefan Koch, Nico Adamini, Sarah Minner, Ronald Simon, Guido Sauter, Tobias Klatte, Thorsten Schlomm, David Horst & Henrik Zecha. (2022) GATA3 expression loss is linked to stage progression but is unrelated to prognosis in muscle-invasive urothelial carcinoma of the bladder. Human Pathology 130, pages 10-17.
Crossref
Lydia Lam, Tien Tien, Mark Wildung, Laura White, Rance K. Sellon, Janean L. Fidel & Eric A. Shelden. (2022) Comparative whole transcriptome analysis of gene expression in three canine soft tissue sarcoma types. PLOS ONE 17:9, pages e0273705.
Crossref
Akshay Sharma, Gatha Thacker, Mukul Mishra, Anil Kumar Singh, Vishal Upadhyay, Sabyasachi Sanyal & Arun Kumar Trivedi. (2022) SOX4-mediated FBW7 transcriptional upregulation confers Tamoxifen resistance in ER+ breast cancers via GATA3 downregulation. Life Sciences 303, pages 120682.
Crossref
Francesca Sanguedolce, Magda Zanelli, Andrea Palicelli, Stefano Ascani, Maurizio Zizzo, Giorgia Cocco, Lars Björnebo, Anna Lantz, Ugo Giovanni Falagario, Luigi Cormio & Giuseppe Carrieri. (2022) Are We Ready to Implement Molecular Subtyping of Bladder Cancer in Clinical Practice? Part 1: General Issues and Marker Expression. International Journal of Molecular Sciences 23:14, pages 7819.
Crossref
Qixin Zhang, Tiezheng Qi, Yu Long, Xiaowen Li, Yiyan Yao, Qi Wu, Anrong Zou, Belaydi Qthmane & Peihua Liu. (2022) GATA3 Predicts the Tumor Microenvironment Phenotypes and Molecular Subtypes for Bladder Carcinoma. Frontiers in Surgery 9.
Crossref
Ryutaro Shimizu, Takahito Ohira, Takuki Yagyu, Tetsuya Yumioka, Noriya Yamaguchi, Hideto Iwamoto, Shuichi Morizane, Katsuya Hikita, Masashi Honda, Atsushi Takenaka & Hiroyuki Kugoh. (2022) Activation of PPARγ in bladder cancer via introduction of the long arm of human chromosome 9. Oncology Letters 23:3.
Crossref
Tejaswi Iyyanki, Baozhen Zhang, Qixuan Wang, Ye Hou, Qiushi Jin, Jie Xu, Hongbo Yang, Tingting Liu, Xiaotao Wang, Fan Song, Yu Luan, Hironobu Yamashita, Ruby Chien, Huijue Lyu, Lijun Zhang, Lu Wang, Joshua Warrick, Jay D. Raman, Joshua J. Meeks, David J. DeGraff & Feng Yue. (2021) Subtype-associated epigenomic landscape and 3D genome structure in bladder cancer. Genome Biology 22:1.
Crossref
Yingying Qi, Kexin Mo & Ting Zhang. (2021) A transcription factor that promotes proliferation, migration, invasion, and epithelial–mesenchymal transition of ovarian cancer cells and its possible mechanisms. BioMedical Engineering OnLine 20:1.
Crossref
Yongchang Li, Wei Zhong, Qianyi Huang, Bing Lang & Xiangqi Tang. (2021) GATA3 improves the protective effects of bone marrow-derived mesenchymal stem cells against ischemic stroke induced injury by regulating autophagy through CREG. Brain Research Bulletin 176, pages 151-160.
Crossref
Tanan Bejrananda, Kanet Kanjanapradit, Jirakrit Saetang & Surasak Sangkhathat. (2021) Impact of immunohistochemistry-based subtyping of GATA3, CK20, CK5/6, and CK14 expression on survival after radical cystectomy for muscle-invasive bladder cancer. Scientific Reports 11:1.
Crossref
Mahdis Khazaeli Najafabadi, Elham Mirzaeian, Sahar Memar Montazerin, Amir Reza Tavangar, Mohammadreza Tabary & Seyed Mohammad Tavangar. (2021) Role of GATA3 in tumor diagnosis: A review. Pathology - Research and Practice 226, pages 153611.
Crossref
Yaowen Zhang, Huitao Wang, Fuyou Zhou, Anlin Hao, Ningtao Dai, Haijun Yang & Anping Zheng. (2021) Identification of crucial long non-coding RNAs and mRNAs along with related regulatory networks through microarray analysis in esophageal carcinoma. Functional & Integrative Genomics 21:3-4, pages 377-391.
Crossref
Peng Chen, Juan Chen, Long He, Cheng Du & Xialu Wang. (2021) Identification of circRNA-miRNA-mRNA Regulatory Network in Bladder Cancer by Integrated Analysis. Urologia Internationalis 105:7-8, pages 705-715.
Crossref
Chaozhi Tang, Jiakang Ma, Xiuli Liu & Zhengchun Liu. (2020) Development and validation of a novel stem cell subtype for bladder cancer based on stem genomic profiling. Stem Cell Research & Therapy 11:1.
Crossref
Hemlata Jangir, Aruna Nambirajan, Amlesh Seth, Ranjit Kumar Sahoo, Amit K. Dinda, Brusabhanu Nayak & Seema Kaushal. (2019) Prognostic stratification of muscle invasive urothelial carcinomas using limited immunohistochemical panel of Gata3 and cytokeratins 5/6, 14 and 20. Annals of Diagnostic Pathology 43, pages 151397.
Crossref
Yue Wang, Jinxia Zhang, Yunfan Wang, Shufang Wang, Yu Zhang, Qi Miao, Fei Gao & Huiying He. (2019) Expression status of GATA3 and mismatch repair proteins in upper tract urothelial carcinoma. Frontiers of Medicine 13:6, pages 730-740.
Crossref
Anna K. Schneider, Mathieu F. Chevalier & Laurent Derré. (2019) The multifaceted immune regulation of bladder cancer. Nature Reviews Urology 16:10, pages 613-630.
Crossref
Yawei Li, Huarong Zhang, You Guo, Hao Cai, Xiangyu Li, Jun He, Hung-Ming Lai, Qingzhou Guan, Xianlong Wang & Zheng Guo. (2019) A Qualitative Transcriptional Signature for Predicting Recurrence Risk of Stage I–III Bladder Cancer Patients After Surgical Resection. Frontiers in Oncology 9.
Crossref
Mingshan Li, Yili Liu, Xiling Zhang, Jie Liu & Ping Wang. (2018) Transcriptomic analysis of high-throughput sequencing about circRNA, lncRNA and mRNA in bladder cancer. Gene 677, pages 189-197.
Crossref
Koji Izumi, Satoshi Inoue, Hiroki Ide, Kazutoshi Fujita, Taichi Mizushima, Guiyang Jiang, Seiji Yamaguchi, Hiroaki Fushimi, Norio Nonomura & Hiroshi Miyamoto. (2018) Uridine 5'diphospho-glucuronosyltransferase 1A expression as an independent prognosticator in urothelial carcinoma of the upper urinary tract. International Journal of Urology 25:5, pages 429-435.
Crossref
Xueying Li, Jiaqi Jin, Siyuan Yang, Weizhi Xu, Xianbin Meng, Haiteng Deng, Jun Zhan, Shan Gao & Hongquan Zhang. (2018) GATA3 acetylation at K119 by CBP inhibits cell migration and invasion in lung adenocarcinoma. Biochemical and Biophysical Research Communications 497:2, pages 633-638.
Crossref
Zhao Yang, Luyun He, Kaisu Lin, Yun Zhang, Aihua Deng, Yong Liang, Chong Li & Tingyi Wen. (2017) The KMT1A-GATA3-STAT3 Circuit Is a Novel Self-Renewal Signaling of Human Bladder Cancer Stem Cells. Clinical Cancer Research 23:21, pages 6673-6685.
Crossref
Satoshi Inoue, Taichi Mizushima, Kazutoshi Fujita, Abdelrazak Meliti, Hiroki Ide, Seiji Yamaguchi, Hiroaki Fushimi, George J. Netto, Norio Nonomura & Hiroshi Miyamoto. (2017) GATA3 immunohistochemistry in urothelial carcinoma of the upper urinary tract as a urothelial marker and a prognosticator. Human Pathology 64, pages 83-90.
Crossref
Renate Pichler, Georg Gruenbacher, Zoran Culig, Andrea Brunner, Dietmar Fuchs, Josef Fritz, Hubert Gander, Andrea Rahm & Martin Thurnher. (2016) Intratumoral Th2 predisposition combines with an increased Th1 functional phenotype in clinical response to intravesical BCG in bladder cancer. Cancer Immunology, Immunotherapy 66:4, pages 427-440.
Crossref
Peng Li, Jinbo Chen & Hiroshi Miyamoto. (2017) Androgen Receptor Signaling in Bladder Cancer. Cancers 9:12, pages 20.
Crossref
Takashi Kawahara, Eiji Kashiwagi, Hiroki Ide, Yi Li, Yichun Zheng, Hitoshi Ishiguro & Hiroshi Miyamoto. (2015) The role of NFATc1 in prostate cancer progression: Cyclosporine A and tacrolimus inhibit cell proliferation, migration, and invasion. The Prostate 75:6, pages 573-584.
Crossref
Hiroki Ide & Hiroshi Miyamoto. (2015) Steroid Hormone Receptor Signals as Prognosticators for Urothelial Tumor. Disease Markers 2015, pages 1-12.
Crossref
Akshay Sharma, Gatha Thacker, Mukul Mishra, Anil Kumar Singh, Vishal Upadhyay, Sabyasachi Sanyal & Arun Kumar Trivedi. (2022) SOX4-Mediated FBW7 Transcriptional Upregulation Confers Tamoxifen Resistance in ER+ Breast Cancers Via GATA3 Downregulation. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.